Volume 87 • 2026 • 1

Editorial

Consensus Statement

Meta-Analysis

Systematic Review

Original Research

JCP
Innovation in Psychiatric Drug Development: A Quantitative Analysis of FDA-Approved Psychiatric Drugs, 2012–2024
JCP
Effect of Concurrent Metformin on Adherence to and Persistence of Treatment With Second-Generation Antipsychotics in Nondiabetic Patients
JCP
Trends in Benzodiazepine Prescribing to Adults in the United States: Results From the Medical Expenditure Panel Survey
JCP
Effects of a Digital Multidomain Cognitive Intervention in Older People at High Risk of Dementia: A Randomized Clinical Trial
JCP
Identifying Optimal Thresholds for Early Opioid Use Frequency in Predicting Buprenorphine Outcomes
JCP
Therapist-Delivered Video Therapy Habit Reversal Training for Body-Focused Repetitive Behaviors: Clinical Outcomes From a Large Real-World Sample of Youth and Adults
JCP
Geographic Differences in Cannabis Use and Cannabis Use Disorder in the US Veteran Population
JCP
How Many Criteria Should Be Required to Define the <strong><em>DSM-5</em></strong> Mixed Features Specifier in Depressed Patients?
JCP
Factors Associated With Revisiting the Emergency Department due to Suicidal Behavior in Children and Adolescents
JCP
Unwanted Intrusive Thoughts of Infant-Related Sexual Harm: Prevalence and Assessment of Safety
JCP
Latency to Long-Acting Injectable Antipsychotic Initiation and Psychiatric Hospitalization in First-Episode Schizophrenia
JCP
The Effects of Extended Cannabis Abstinence in Comorbid Posttraumatic Stress Disorder and Cannabis Use Disorder
JCP
Suicidality in Postpartum Women With Unipolar and Bipolar Depression: A Secondary Analysis Comparing Self-Reported and Clinician Assessments
JCP
Targeting Intolerance of Uncertainty During Pregnancy: A Randomized Controlled Trial to Prevent Postpartum Anxiety Disorders
JCP
Triple Network Model–Based Functional Dysconnectivity in Young People With Major Affective Disorders With or Without Current Suicidal Ideation
JCP
Lack of Generalizability of PTSD Treatment Trials: The Recent Brexpiprazole-Sertraline Trials as an Example
JCP
HIV Diagnosis and Preexposure Prophylaxis (PrEP) Prescription Among Commercially Insured Persons With Bipolar Disorder
JCP
Obstetric Outcomes With Second-Generation Long-Acting Injectable Versus Oral Antipsychotics
JCP
Valproic Acid Use Trends, Patterns, and Predictors in Females of Reproductive Age in the United States
JCP
Risk Factors for Suicide Attempts and Psychiatric Hospitalization Among Brazilian Health Care Professionals

Commentary

Clinical and Practical Psychopharmacology

ASCP Corner

Brief Report

Case Series

Letter to the Editor

JCP
Urological Commentary on Ketamine-Associated Uropathy
JCP
Ketamine-Associated Uropathy in Therapeutic Contexts: Reply to Abdelrahman
JCP
Rationale for Clozapine Trial
JCP
The Position of Clozapine in Patients With Treatment-Resistant Schizophrenia: Reply to Mattes
JCP
Racemic Ketamine vs Esketamine in Treatment-Resistant Depression: The Overlooked Role of Arketamine
JCP
Exposure Therapy for Perinatal OCD: Navigating Evidence and Discomfort
JCP
Burnout in Psychiatric Doctors Before and After COVID-19: A Critical Commentary
JCP
Reframing the Discussion on Finasteride and Neuropsychiatric Safety: A Call for Balanced Interpretation
JCP
Finasteride-Induced Neuropsychiatric Reactions: No Room for Complacency